Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Haefeli

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Methods of Information in Medicine|November 9, 2010
Design and evaluation of an ontology-based drug application databaseC Senger, H M Seidling, R Quinzler, et al.
Schweizerische Medizinische Wochenschrift|July 17, 1999
[Tablets in stool? A common problem!]L V Schuerch, J Nyfeler, G Holder, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 5, 1997
Haunting medicinesL V Schuerch, J Nyfeler, G Holder, et al.
Lancet (London, England)|July 8, 1998
Rhabdomyolysis due to interaction of simvastatin with mibefradilD Schmassmann-Suhijar, R Bullingham, R Gasser, et al.
Clinical Pharmacology and Therapeutics|December 1, 1995
Neuropeptide Y in human hand veins: pharmacologic characterization and interaction with cyclic guanosine monophosphate-dependent venodilators in vivoP Peduzzi, D Simper, L Linder, et al.
The American Journal of Cardiology|May 1, 1991
Concentration-effect relations of 5-hydroxypropafenone in normal subjectsW E Haefeli, S Vozeh, H R Ha, et al.
European Journal of Clinical Investigation|December 3, 1999
Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and ageL Todesco, C Angst, P Litynski, et al.
Clinical Pharmacology and Therapeutics|October 1, 1996
Substance P in human hand veins in vivo: tolerance, efficacy, potency, and mechanism of venodilator actionW M Strobel, T F Lüscher, D Simper, et al.
Pharmacogenetics|January 26, 1999
Acetaminophen is an inhibitor of hepatic N-acetyltransferase 2 in vitro and in vivoJ P Rothen, W E Haefeli, U A Meyer, et al.
Thrombosis and Haemostasis|September 1, 1995
Platelet surface activation markers after DDAVP infusion in healthy subjectsD A Tsakiris, W E Haefeli, L Linder, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Methods of Information in Medicine|November 9, 2010
Design and evaluation of an ontology-based drug application databaseC Senger, H M Seidling, R Quinzler, et al.
Schweizerische Medizinische Wochenschrift|July 17, 1999
[Tablets in stool? A common problem!]L V Schuerch, J Nyfeler, G Holder, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 5, 1997
Haunting medicinesL V Schuerch, J Nyfeler, G Holder, et al.
Lancet (London, England)|July 8, 1998
Rhabdomyolysis due to interaction of simvastatin with mibefradilD Schmassmann-Suhijar, R Bullingham, R Gasser, et al.
Clinical Pharmacology and Therapeutics|December 1, 1995
Neuropeptide Y in human hand veins: pharmacologic characterization and interaction with cyclic guanosine monophosphate-dependent venodilators in vivoP Peduzzi, D Simper, L Linder, et al.
The American Journal of Cardiology|May 1, 1991
Concentration-effect relations of 5-hydroxypropafenone in normal subjectsW E Haefeli, S Vozeh, H R Ha, et al.
European Journal of Clinical Investigation|December 3, 1999
Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and ageL Todesco, C Angst, P Litynski, et al.
Clinical Pharmacology and Therapeutics|October 1, 1996
Substance P in human hand veins in vivo: tolerance, efficacy, potency, and mechanism of venodilator actionW M Strobel, T F Lüscher, D Simper, et al.
Pharmacogenetics|January 26, 1999
Acetaminophen is an inhibitor of hepatic N-acetyltransferase 2 in vitro and in vivoJ P Rothen, W E Haefeli, U A Meyer, et al.
Thrombosis and Haemostasis|September 1, 1995
Platelet surface activation markers after DDAVP infusion in healthy subjectsD A Tsakiris, W E Haefeli, L Linder, et al.
Pageof 14